Gadducci A - Search Results

1

Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women.

Strigini FA, Gadducci A, Del Bravo B, Ferdeghini M, Genazzani AR. Strigini FA, et al. Among authors: gadducci a. Gynecol Oncol. 1996 Apr;61(1):68-72. doi: 10.1006/gyno.1996.0098. Gynecol Oncol. 1996. PMID: 8626120

2

The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis.

Gadducci A, Ferdeghini M, Prontera C, Moretti L, Mariani G, Bianchi R, Fioretti P. Gadducci A, et al. Gynecol Oncol. 1992 Feb;44(2):147-54. doi: 10.1016/0090-8258(92)90030-m. Gynecol Oncol. 1992. PMID: 1312052

3

Preoperative evaluation of CA 125 and CA 19-9 serum levels in patients with ovarian masses.

Fioretti P, Gadducci A, Ferdeghini M, Bartolini T, Fontana V, Facchini V. Fioretti P, et al. Among authors: gadducci a. Eur J Gynaecol Oncol. 1988;9(4):291-4. Eur J Gynaecol Oncol. 1988. PMID: 3164674

4

Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma.

Fioretti P, Gadducci A, Ferdeghini M, Bartolini T, Bianchi R, Facchini V. Fioretti P, et al. Among authors: gadducci a. Gynecol Oncol. 1987 Nov;28(3):278-83. doi: 10.1016/0090-8258(87)90173-9. Gynecol Oncol. 1987. PMID: 3479380

5

Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinoma.

Gadducci A, Baicchi U, Marrai R, Del Bravo B, Fosella PV, Facchini V. Gadducci A, et al. Gynecol Oncol. 1994 Jun;53(3):352-6. doi: 10.1006/gyno.1994.1146. Gynecol Oncol. 1994. PMID: 8206409

6

Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.

Gadducci A, Marrai R, Baicchi U, Gagetti O, Facchini V, Genazzani AR. Gadducci A, et al. Gynecol Oncol. 1996 May;61(2):215-7. doi: 10.1006/gyno.1996.0127. Gynecol Oncol. 1996. PMID: 8626135

7

Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses.

Gadducci A, Baicchi U, Marrai R, Ferdeghini M, Bianchi R, Facchini V. Gadducci A, et al. Gynecol Oncol. 1996 Feb;60(2):197-202. doi: 10.1006/gyno.1996.0025. Gynecol Oncol. 1996. PMID: 8631538

8

Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer.

Gadducci A, Marrai R, Baicchi U, Ferdeghini M, Fanucchi A, Weiss C, Genazzani AR. Gadducci A, et al. Gynecol Oncol. 1997 Jul;66(1):85-8. doi: 10.1006/gyno.1997.4704. Gynecol Oncol. 1997. PMID: 9234926 Clinical Trial.

9

Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.

Gadducci A, Ferdeghini M, Castellani C, Annicchiarico C, Prontera C, Facchini V, Bianchi R, Genazzani AR. Gadducci A, et al. Gynecol Oncol. 1998 Jul;70(1):111-4. doi: 10.1006/gyno.1998.4259. Gynecol Oncol. 1998. PMID: 9698485

10

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer.

Gadducci A, Ferdeghini M, Buttitta F, Cosio S, Fanucchi A, Annicchiarico C, Gagetti O, Bevilacqua G, Genazzani AR. Gadducci A, et al. Gynecol Oncol. 1999 Jan;72(1):76-81. doi: 10.1006/gyno.1998.5101. Gynecol Oncol. 1999. PMID: 9889034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters